Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Three-Arm Parallel-group Exploratory Trial documents balance improvement without much evidence of white matter integrity changes in people with multiple sclerosis following two months ambulatory neuroproprioceptive "facilitation and inhibition" physical therapy.
Řasová K, Bučková B, Prokopiusová T, Procházková M, Angel G, Marková M, Hrušková N, Štětkářová I, Špaňhelová Š, Mareš J, Tintěra J, Zach P, Musil V, Hlinka J. Řasová K, et al. Among authors: markova m. Eur J Phys Rehabil Med. 2021 Dec;57(6):889-899. doi: 10.23736/S1973-9087.21.06701-0. Epub 2021 Feb 10. Eur J Phys Rehabil Med. 2021. PMID: 33565742 Free article. Clinical Trial.
Randomized comparison of functional electric stimulation in posturally corrected position and motor program activating therapy: treating foot drop in people with multiple sclerosis.
Prokopiusova T, Pavlikova M, Markova M, Rasova K. Prokopiusova T, et al. Among authors: markova m. Eur J Phys Rehabil Med. 2020 Aug;56(4):394-402. doi: 10.23736/S1973-9087.20.06104-3. Epub 2020 May 8. Eur J Phys Rehabil Med. 2020. PMID: 32383574 Free article. Clinical Trial.
Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Improves Clinical Outcomes in Multiple Sclerosis and Modulates Serum Level of Neuroactive Steroids: A Two-Arm Parallel-Group Exploratory Trial.
Angelova G, Skodova T, Prokopiusova T, Markova M, Hruskova N, Prochazkova M, Pavlikova M, Spanhelova S, Stetkarova I, Bicikova M, Kolatorova L, Rasova K. Angelova G, et al. Among authors: markova m. Life (Basel). 2020 Oct 31;10(11):267. doi: 10.3390/life10110267. Life (Basel). 2020. PMID: 33142850 Free PMC article.
The impact of balance specific physiotherapy, intensity of therapy and disability on static and dynamic balance in people with multiple sclerosis: A multi-center prospective study.
Pavlikova M, Cattaneo D, Jonsdottir J, Gervasoni E, Stetkarova I, Angelova G, Markova M, Prochazkova M, Prokopiusova T, Hruskova N, Reznickova J, Zimova D, Spanhelova S, Rasova K. Pavlikova M, et al. Among authors: markova m. Mult Scler Relat Disord. 2020 May;40:101974. doi: 10.1016/j.msard.2020.101974. Epub 2020 Jan 30. Mult Scler Relat Disord. 2020. PMID: 32044695 Clinical Trial.
First Study of the ^{139}Ba(n,γ)^{140}Ba Reaction to Constrain the Conditions for the Astrophysical i Process.
Spyrou A, Mücher D, Denissenkov PA, Herwig F, Good EC, Balk G, Berg HC, Bleuel DL, Clark JA, Dembski C, DeYoung PA, Greaves B, Guttormsen M, Harris C, Larsen AC, Liddick SN, Lyons S, Markova M, Mogannam MJ, Nikas S, Owens-Fryar J, Palmisano-Kyle A, Perdikakis G, Pogliano F, Quintieri M, Richard AL, Santiago-Gonzalez D, Savard G, Smith MK, Sweet A, Tsantiri A, Wiedeking M. Spyrou A, et al. Among authors: markova m. Phys Rev Lett. 2024 May 17;132(20):202701. doi: 10.1103/PhysRevLett.132.202701. Phys Rev Lett. 2024. PMID: 38829093
Lupus progression deteriorates oogenesis quality in MRL/lpr mice.
Delimitreva S, Boneva G, Chakarova I, Hadzhinesheva V, Zhivkova R, Markova M, Nikolova V, Kolarov A, Mladenov N, Bradyanova S, Prechl J, Mihaylova N, Tchorbanov A. Delimitreva S, et al. Among authors: markova m. Immunol Res. 2024 May 21. doi: 10.1007/s12026-024-09489-2. Online ahead of print. Immunol Res. 2024. PMID: 38771487
Frailty and Cognitive Function in Middle-Aged and Older Adults With Congenital Heart Disease.
Daelman B, Van Bulck L, Luyckx K, Kovacs AH, Van De Bruaene A, Ladouceur M, Yang HL, Moon JR, Schmidt A, Lykkeberg B, Callus E, de Hosson M, Sandberg C, Johansson B, Hlebowicz J, Areias ME, Amedro P, Coats L, Mandalenakis Z, Kaneva A, Moons P, Goossens E; APPROACH-IS II consortium; International Society for Adult Congenital Heart Disease. Daelman B, et al. J Am Coll Cardiol. 2024 Mar 26;83(12):1149-1159. doi: 10.1016/j.jacc.2024.01.021. J Am Coll Cardiol. 2024. PMID: 38508848
220 results